Physiological, pharmacological and clinical features of the multidrug resistance protein 2

This publication has 145 references indexed in Scilit:

• Interleukin-6 regulates hepatic transporters during acute-phase response
  Biochemical and Biophysical Research Communications, 2004
• Effects of Proinflammatory Cytokines on Rat Organic Anion Transporters During Toxic Liver Injury and Cholestasis
  Hepatology, 2003
• Overexpression of cMOAT (MRP2/ABCC2) Is Associated with Decreased Formation of Platinum-DNA Adducts and Decreased G2-Arrest in Melanoma Cells Resistant to Cisplatin
  Journal of Investigative Dermatology, 2003
• Role of the N-terminal Transmembrane Region of the Multidrug Resistance Protein MRP2 in Routing to the Apical Membrane in MDCKII Cells
  Published by Elsevier ,2002
• Role of MRP2 and GSH in intrahepatic cycling of toxins
  Toxicology, 2001
• Identification and Functional Analysis of Two Novel Mutations in the Multidrug Resistance Protein 2 Gene in Israeli Patients with Dubin-Johnson Syndrome
  Journal of Biological Chemistry, 2001
• Reactive Oxygen Species-Related Induction of Multidrug Resistance-Associated Protein 2 Expression in Primary Hepatocytes Exposed to Sulforaphane
  Biochemical and Biophysical Research Communications, 2001
• Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2
  Hepatology, 1999
• Sequence Analysis and Functional Characterization of the 5′-Flanking Region of the Rat Multidrug Resistance Protein 2 (MRP2) Gene
  Biochemical and Biophysical Research Communications, 1998
• Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
  Seminars in Cancer Biology, 1997